Earl F. Albone
Precision Therapeutics (United States)(US)Eisai (United States)(US)Eisai (Japan)(JP)
Publications by Year
Research Areas
HER2/EGFR in Cancer Research, Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, Radiopharmaceutical Chemistry and Applications, Cancer Treatment and Pharmacology
Most-Cited Works
- → Pre-clinical characterisation of E2814, a high-affinity antibody targeting the microtubule-binding repeat domain of tau for passive immunotherapy in Alzheimer’s disease(2020)125 cited
- → Bioconjugation by Native Chemical Tagging of C–H Bonds(2013)105 cited
- → MORAb-202, an Antibody–Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity(2018)89 cited
- → Characterization of the Human Folate Receptor Alpha Via Novel Antibody-Based Probes(2011)71 cited
- → The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity(2013)54 cited
- → Single Dose GLP-1-Tf Ameliorates Myocardial Ischemia/Reperfusion Injury(2009)54 cited